Compare BIO & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIO | PATH |
|---|---|---|
| Founded | 1952 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 7.9B |
| IPO Year | N/A | 2021 |
| Metric | BIO | PATH |
|---|---|---|
| Price | $298.85 | $12.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 15 |
| Target Price | ★ $358.50 | $15.50 |
| AVG Volume (30 Days) | 232.0K | ★ 27.8M |
| Earning Date | 02-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | ★ $2,557,500,000.00 | $1,553,111,000.00 |
| Revenue This Year | $1.50 | $13.59 |
| Revenue Next Year | $2.23 | $9.54 |
| P/E Ratio | ★ N/A | $28.73 |
| Revenue Growth | N/A | ★ 10.05 |
| 52 Week Low | $211.43 | $9.38 |
| 52 Week High | $351.02 | $19.84 |
| Indicator | BIO | PATH |
|---|---|---|
| Relative Strength Index (RSI) | 46.43 | 34.07 |
| Support Level | $298.09 | $11.62 |
| Resistance Level | $307.41 | $12.53 |
| Average True Range (ATR) | 8.89 | 0.67 |
| MACD | -0.23 | -0.22 |
| Stochastic Oscillator | 49.88 | 19.33 |
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.